Global Smart Inhalers Market Demand, Competitive Landscape and Business Outlook 2022-2030

The global Smart Inhalers Market size was valued at USD 113.8 Million in 2021 and is projected to reach USD 2,190.2 Million by 2030 growing at a CAGR of 38.9% from 2022 to 2030. Smart Inhalers are devices medical devices, used to deliver a variety of medications by inhalation. Smart inhalers can be connected to a smart phone or any other digital device to regularly monitor the health of the patient. Additionally, these smart devices are capable of triggering reminders and alerts for users based on the previous regimen of dosage administration. Additionally, these inhalers can send alerts, notifying the patient of polluted areas where the pollen threat is high.

Market Segmentation and Scope of the Study:

The smart inhaler market size is segmented on the basis of product, indication, distribution channels and geography. Based on product, the industry is categorized into inhalers and nebulizers. The inhaler segment is further classified into metered dose inhalers (MDIs) and dry powder inhalers (DPIs). Based on the indication, the industry is divided into asthma and COPD. Based on distribution channels, the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The geographic breakdown and analysis of each of the aforementioned segments includes regions including North America, Europe, Asia-Pacific and ROW.

Free sample request-

Geographical analysis

North America holds the lion’s share of the global smart inhaler market and is expected to continue dominating the market during the forecast period. This is attributed to factors such as favorable reimbursement in the medical sector, people’s greater awareness of digital medicines, and higher per capita income. However, Asia-Pacific is expected to show a steady increase in the smart inhaler market owing to high investments in the healthcare sector. Furthermore, factors such as increasing digitalization in the healthcare sector, flexible government policies, and widespread diseases such as asthma and COPD among the population are propelling the demand for smart inhalers in this region.

Ask before you buy-

Competitive landscape

The market includes various players such as Teva Pharmaceuticals, RYAH Medtech Inc., 3M Company, Novartis AG, Vectura Group, AstraZeneca, Cohero Health, Glaxo Smith Kline, Adherium, and Inspiro Medical. These manufacturers actively engage in R&D initiatives, product and technology innovations, and industry collaborations to improve their product and increase their growth and geographic reach. For example, in September 2020, Teva Pharmaceutical launched two digital inhalers, Air Duo Digihaler Inhalation Powder and Armon Air Digihaler Inhalation Powder. AirDuo Digihaler inhalation powder inhalers are useful for patients with early stage asthma, while Armon Air Digihaler inhalation powder inhalers are for long-term treatment of asthma in 12-year-old patients and more. Additionally, in May 2021, RYAH Medtech Inc. signed an agreement with Delled SAS which is involved in product distribution and software development rights. This agreement is concluded for the distribution of the RYAH smart inhaler in the market.

About Us:

Next Move Strategy Consulting is a trusted, independent third-platform market intelligence provider committed to delivering high-quality market research reports that help multinational companies triumph over their competitors and grow their footprint in the industry by capturing a larger market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analysis. We carefully analyze historical data, augment it by constantly keeping an eye on the latest industry trends and estimate future events to arrive at accurate market forecasts.

For more information, please visit,